What is I3LUNG
I3LUNG is a European project funded under the framework of the Horizon Europe (HEurope) call “Ensuring access to innovative, sustainable and high-quality health care”. Our consortium gathers 16 partners with different expertise located worldwide, with the common goal of providing better assistance and individualize treatment for patients affected by metastatic lung cancer.
For Patients
In the video below the project explained by Anne-Marie Baird, President of Lung Cancer Europe (LuCE) (one of the partners of the I3LUNG).
“We are excited to start this project which is envisioned to both generate novel therapeutic guidelines for clinical practice in lung cancer and support the growth of digital diagnostic tools in the European industry. (I3LUNG Partners)„
Find out the most relevant news on the latest advancements in lung cancer!
News
October, 10 2024
Today, on World Mental Health Day, the I3LUNG project emphasizes the importance of mental health. Since the project’s inception, we […]
News
September, 13 2024
Last Thursday, 12th of September, MEDSIR organized an insightful event titled “10 Years from Now – The Future of Breast […]
News
September, 13 2024
Another day, another partner going all out. Massimo Broggini, Head Department of Experimental Oncology, from Istituto Mario Negri participated in […]